MX2022016100A - Procedimientos para la detección y predicción de neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer. - Google Patents
Procedimientos para la detección y predicción de neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer.Info
- Publication number
- MX2022016100A MX2022016100A MX2022016100A MX2022016100A MX2022016100A MX 2022016100 A MX2022016100 A MX 2022016100A MX 2022016100 A MX2022016100 A MX 2022016100A MX 2022016100 A MX2022016100 A MX 2022016100A MX 2022016100 A MX2022016100 A MX 2022016100A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- individual
- assays
- absence
- development
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 8
- 201000011510 cancer Diseases 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 4
- 238000003556 assay Methods 0.000 abstract 3
- 206010014733 Endometrial cancer Diseases 0.000 abstract 2
- 206010014759 Endometrial neoplasm Diseases 0.000 abstract 2
- 206010033128 Ovarian cancer Diseases 0.000 abstract 2
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 2
- 230000002357 endometrial effect Effects 0.000 abstract 2
- 230000011987 methylation Effects 0.000 abstract 2
- 238000007069 methylation reaction Methods 0.000 abstract 2
- 238000003491 array Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2009224.3A GB202009224D0 (en) | 2020-06-17 | 2020-06-17 | Methods for detecting and predicting cancer and/or cin3 |
| GBGB2107412.5A GB202107412D0 (en) | 2021-05-25 | 2021-05-25 | Methods for detecting and predicting cancer and/or CIN3 |
| PCT/GB2021/051536 WO2021255459A1 (en) | 2020-06-17 | 2021-06-17 | Methods for detecting and predicting cancer and/or cin3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022016100A true MX2022016100A (es) | 2023-04-20 |
Family
ID=76730905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022016100A MX2022016100A (es) | 2020-06-17 | 2021-06-17 | Procedimientos para la detección y predicción de neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240191302A1 (https=) |
| EP (1) | EP4168587A1 (https=) |
| JP (1) | JP2023530983A (https=) |
| KR (1) | KR20230024344A (https=) |
| AU (1) | AU2021291133A1 (https=) |
| BR (1) | BR112022025789A2 (https=) |
| CA (1) | CA3186997A1 (https=) |
| IL (1) | IL299142A (https=) |
| MX (1) | MX2022016100A (https=) |
| WO (1) | WO2021255459A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202315787D0 (en) * | 2023-10-16 | 2023-11-29 | Sola Diagnostics Gmbh | Method |
| GB202401477D0 (en) * | 2024-02-05 | 2024-03-20 | Sola Diagnostics Gmbh | Method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013033627A2 (en) * | 2011-09-01 | 2013-03-07 | The Regents Of The University Of California | Diagnosis and treatment of arthritis using epigenetics |
| WO2016041010A1 (en) * | 2014-09-15 | 2016-03-24 | Garvan Institute Of Medical Research | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor |
| US9984201B2 (en) * | 2015-01-18 | 2018-05-29 | Youhealth Biotech, Limited | Method and system for determining cancer status |
| JP7299158B2 (ja) * | 2017-03-10 | 2023-06-27 | セルフ－スクリーン ベー．フェー． | Ｈｐｖ誘発浸潤がん、非ｈｐｖ誘発婦人科がん及び肛門性器がん、並びにその高度前駆病変を検出するためのメチル化分類子 |
| US12480164B2 (en) * | 2018-12-04 | 2025-11-25 | EpiMedTechGlobal (EMTG) | DNA methylation biomarkers for early detection of cervical cancer |
-
2021
- 2021-06-17 US US18/009,945 patent/US20240191302A1/en active Pending
- 2021-06-17 AU AU2021291133A patent/AU2021291133A1/en active Pending
- 2021-06-17 JP JP2022577444A patent/JP2023530983A/ja active Pending
- 2021-06-17 KR KR1020237000635A patent/KR20230024344A/ko active Pending
- 2021-06-17 WO PCT/GB2021/051536 patent/WO2021255459A1/en not_active Ceased
- 2021-06-17 BR BR112022025789A patent/BR112022025789A2/pt unknown
- 2021-06-17 EP EP21736665.7A patent/EP4168587A1/en active Pending
- 2021-06-17 MX MX2022016100A patent/MX2022016100A/es unknown
- 2021-06-17 CA CA3186997A patent/CA3186997A1/en active Pending
- 2021-06-17 IL IL299142A patent/IL299142A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3186997A1 (en) | 2021-12-23 |
| BR112022025789A2 (pt) | 2023-01-10 |
| WO2021255459A1 (en) | 2021-12-23 |
| JP2023530983A (ja) | 2023-07-20 |
| AU2021291133A1 (en) | 2023-02-02 |
| KR20230024344A (ko) | 2023-02-20 |
| EP4168587A1 (en) | 2023-04-26 |
| US20240191302A1 (en) | 2024-06-13 |
| IL299142A (en) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jeon et al. | AutoVAS: An automated vulnerability analysis system with a deep learning approach | |
| Viuff et al. | Epigenetics and genomics in Turner syndrome | |
| Gevensleben et al. | PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy | |
| Kim et al. | HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array‐based DNA methylation and expression profiling | |
| De Cecco et al. | Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor | |
| Buhule et al. | Stratified randomization controls better for batch effects in 450K methylation analysis: a cautionary tale | |
| EP3839510A3 (en) | Blood-based biomarkers of tumor sensitivity to pd-1 antagonists | |
| CN113838531B (zh) | 一种基于转录组数据和机器学习策略评估细胞衰老程度的方法 | |
| MX2022016100A (es) | Procedimientos para la detección y predicción de neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer. | |
| WO2020132544A8 (en) | Anomalous fragment detection and classification | |
| Sun et al. | Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway. | |
| Woo et al. | Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐and cancer‐associated DNA methylome changes | |
| WO2021133993A3 (en) | Methods and systems for molecular disease assessment via analysis of circulating tumor dna | |
| MY145455A (en) | Diagnostic biomolecule(s) | |
| Li et al. | Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma | |
| Meng et al. | Occupational lead exposure on genome-wide DNA methylation and DNA damage | |
| Melani et al. | Liquid biopsy in non‐Hodgkin's lymphoma | |
| Litvinov et al. | The role of AHI 1 and CDKN 1C in cutaneous T‐cell lymphoma progression | |
| US20220380853A1 (en) | Prostate cancer detection methods | |
| He et al. | TRIM36 hypermethylation is involved in polycyclic aromatic hydrocarbons-induced cell transformation | |
| MX2022016097A (es) | Procedimientos para detectar y predecir neoplasia epitelial cervical de grado 3 (cin3) y/o cáncer. | |
| Krishnan et al. | Computational methods reveal novel functionalities of PIWI-interacting RNAs in human papillomavirus-induced head and neck squamous cell carcinoma | |
| CN116261601A8 (zh) | 用于检测和预测癌症的方法 | |
| Beentjes et al. | DNA methylation-based forensic framework for age prediction and body fluid identification using nanopore sequencing | |
| Ballhausen et al. | The shared neo antigen landscape of MSI cancers reflects immunoediting during tumor evolution |